Targeted Treatment of Advanced Endometrial Cancer: Focus on Pembrolizumab.
endometrial cancer
immunotherapy
pembrolizumab
precision medicine
Journal
OncoTargets and therapy
ISSN: 1178-6930
Titre abrégé: Onco Targets Ther
Pays: New Zealand
ID NLM: 101514322
Informations de publication
Date de publication:
2023
2023
Historique:
received:
16
02
2023
accepted:
30
03
2023
medline:
8
6
2023
pubmed:
8
6
2023
entrez:
8
6
2023
Statut:
epublish
Résumé
Endometrial cancer (EC) accounts for 2% of all new cancers. Advanced forms have a poor prognosis with barely 17% 5-year survival. The last few years improved our knowledge of EC with a new molecular classification derived from The Cancer Genome Atlas (TCGA). They are now divided between
Identifiants
pubmed: 37288137
doi: 10.2147/OTT.S368050
pii: 368050
pmc: PMC10243542
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
359-369Informations de copyright
© 2023 El-ghazzi et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Lancet Oncol. 2014 Jun;15(7):e268-78
pubmed: 24872110
J Clin Oncol. 2020 Sep 10;38(26):2981-2992
pubmed: 32167863
JAMA Oncol. 2021 Dec 1;7(12):1791-1799
pubmed: 34617955
Cancers (Basel). 2022 Jan 27;14(3):
pubmed: 35158919
Cancer Immunol Res. 2019 Oct;7(10):1570-1573
pubmed: 31405947
Nature. 2013 May 2;497(7447):67-73
pubmed: 23636398
Br J Cancer. 2015 Jul 14;113(2):299-310
pubmed: 26172027
Am J Obstet Gynecol. 2021 Sep;225(3):237.e1-237.e24
pubmed: 33957111
PLoS One. 2019 Feb 27;14(2):e0212513
pubmed: 30811474
Br J Cancer. 2018 Oct;119(9):1067-1074
pubmed: 30356126
Gynecol Oncol. 1983 Feb;15(1):10-7
pubmed: 6822361
Gynecol Oncol. 2020 Jan;156(1):194-202
pubmed: 31757464
Gynecol Oncol. 2019 Jul;154(1):29-37
pubmed: 31130288
Expert Rev Anticancer Ther. 2009 Jul;9(7):905-16
pubmed: 19589030
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e631-8
pubmed: 21640520
J Clin Oncol. 2019 Sep 20;37(27):2501-2509
pubmed: 31403865
Gynecol Oncol. 2017 Oct;147(1):158-166
pubmed: 28689667
Gynecol Oncol. 2013 Dec;131(3):567-73
pubmed: 24076450
Gynecol Oncol. 2013 Sep;130(3):452-6
pubmed: 23774300
Front Oncol. 2020 Apr 30;10:632
pubmed: 32426281
Lancet. 2016 Mar 12;387(10023):1094-1108
pubmed: 26354523
Lancet Oncol. 2020 Oct;21(10):1353-1365
pubmed: 32919526
N Engl J Med. 2018 Nov 22;379(21):2040-2051
pubmed: 30280635
Int J Gynecol Pathol. 2022 May 1;41(3):227-234
pubmed: 34392268
Int J Gynecol Cancer. 2022 Jan;32(1):93-100
pubmed: 34799418
J Immunother Cancer. 2022 Jan;10(1):
pubmed: 35064011
N Engl J Med. 2021 Nov 11;385(20):1856-1867
pubmed: 34534429
Ann Oncol. 2022 Sep;33(9):860-877
pubmed: 35690222
Cancer Causes Control. 2019 Apr;30(4):355-363
pubmed: 30788634
Cancer Res. 2010 Aug 1;70(15):6171-80
pubmed: 20631075
Genome Med. 2017 Apr 19;9(1):34
pubmed: 28420421
J Pathol. 2020 Mar;250(3):336-345
pubmed: 31829441
Lancet. 2003 Jun 21;361(9375):2099-106
pubmed: 12826431
Int J Mol Sci. 2019 May 12;20(9):
pubmed: 31083638
N Engl J Med. 2022 Feb 3;386(5):437-448
pubmed: 35045221
Ann Oncol. 2017 Jan 1;28(1):96-102
pubmed: 27742654
Cancer Treat Rev. 2007 Apr;33(2):177-90
pubmed: 17196749
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
J Clin Oncol. 2020 Jan 1;38(1):1-10
pubmed: 31682550
J Clin Oncol. 2022 Mar 1;40(7):752-761
pubmed: 34990208
Diagnostics (Basel). 2022 Feb 25;12(3):
pubmed: 35328145
Am J Surg Pathol. 2013 Jun;37(6):874-81
pubmed: 23629444
Ann Oncol. 2018 May 1;29(5):1180-1188
pubmed: 29432521
Ann Oncol. 2021 Aug;32(8):1045-1046
pubmed: 33932502
J Pathol. 2018 Apr;244(5):538-549
pubmed: 29344951
N Engl J Med. 2015 Jul 2;373(1):23-34
pubmed: 26027431
Lancet Oncol. 2019 May;20(5):711-718
pubmed: 30922731
N Engl J Med. 2018 May 31;378(22):2078-2092
pubmed: 29658856
Gynecol Oncol Res Pract. 2017 Dec 2;4:19
pubmed: 29214032
J Clin Oncol. 2017 Aug 1;35(22):2535-2541
pubmed: 28489510
Diabetologia. 2007 Jul;50(7):1365-74
pubmed: 17476474
Gynecol Oncol. 2009 Feb;112(2):337-41
pubmed: 19041126
Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S64-S74
pubmed: 30550484
JAMA Netw Open. 2021 Jul 1;4(7):e2118603
pubmed: 34319360
Int J Gynecol Pathol. 2022 May 1;41(3):220-226
pubmed: 34261899
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Clin Oncol. 2020 Nov 20;38(33):3841-3850
pubmed: 33078978
J Immunother Cancer. 2022 Dec;10(12):
pubmed: 36581331
Clin Cancer Res. 2014 Nov 1;20(21):5384-91
pubmed: 25204552
J Cancer. 2020 Jan 1;11(4):776-780
pubmed: 31949479